MiNK Therapeutics Reports Corporate Update and Second Quarter 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to MiNK Therapeutics Reports Corporate Update and Second Quarter 2022 Financial Results
(NASDAQ: INKT) Delayed: 12.33 +0.08 (0.65%)
Previous Close $12.25    52 Week High $ 
Open $11.88    52 Week Low $ 
Day High $12.58    P/E N/A 
Day Low $11.88    EPS $ 
Volume 22,907